National Symposium 2015

214 - Assessment and Evidence-Based Management of Clostridium Difficile

Apr 21, 2015 10:30am ‐ Apr 21, 2015 11:45am


Credits: None available.

Standard: $20.00
Members: $0.00

Description

Contact hours available until 4/22/17.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:
• Denise Murcek – Employee, Fresenius Medical Care
• Dawn Koonkongsatian – Employee, Fresenius Medical Care
• Melissa Nesmith-Vester – Employee, Aegerion
• Elizabeth St. John - Employee, Fresenius Medical Care
• Kyra Trappett – Employee, DaVita

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.

Objectives:

  • Describe incidence of Clostridrium difficile (C. difficile) in the CKD vs. general population.
  • Outline assessment methods for determining C. difficile infection.
  • Propose pharmacologic and non-pharmacologic treatment considerations for the individual with C. difficile infection.

Speaker(s):

Credits Available


You must be logged in and own this session in order to post comments.

Nancy Murphy
5/30/17 11:48 am

Very good coarse! Not aware of the FDA's requirements. very sad for our dialysis patients. I know of 3 deaths and only one transplant in recent years. Thank you!